Regulation of p53 downstream genes
- PMID: 10101800
- DOI: 10.1006/scbi.1998.0097
Regulation of p53 downstream genes
Abstract
The p53 tumor suppressor is the most commonly mutated gene in human cancer. p53 protein is stabilized in response to different checkpoints activated by DNA damage, hypoxia, viral infection, or oncogene activation resulting in diverse biological effects, such as cell cycle arrest, apoptosis, senescence, differentiation, and antiangiogenesis. The stable p53 protein is activated by phosphorylation, dephosphorylation and acetylation yielding a potent sequence-specific DNA-binding transcription factor. The wide range of p53's biological effects can in part be explained by its activation of expression of a number of target genes including p21WAFI, GADD45, 14-3-3 sigma, bax, Fas/APO1, KILLER/DR5, PIG3, Tsp1, IGF-BP3 and others. This review will focus on the transcriptional targets of p53, their regulation by p53, and their relative importance in carrying out the biological effects of p53.
Similar articles
-
[Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].Rev Invest Clin. 2001 May-Jun;53(3):266-73. Rev Invest Clin. 2001. PMID: 11496714 Review. Spanish.
-
Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.Oncogene. 2001 Aug 2;20(34):4601-12. doi: 10.1038/sj.onc.1204484. Oncogene. 2001. PMID: 11498783
-
The role of p53-target genes in human cancer.Crit Rev Oncol Hematol. 2000 Jan;33(1):1-6. doi: 10.1016/s1040-8428(99)00051-7. Crit Rev Oncol Hematol. 2000. PMID: 10714958 Review.
-
Identification of a novel p53 functional domain that is necessary for efficient growth suppression.Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15335-40. doi: 10.1073/pnas.93.26.15335. Proc Natl Acad Sci U S A. 1996. PMID: 8986812 Free PMC article.
-
Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.Oncogene. 2000 Mar 30;19(14):1735-43. doi: 10.1038/sj.onc.1203489. Oncogene. 2000. PMID: 10777207
Cited by
-
The Intersection of DNA Damage Response and Ferroptosis-A Rationale for Combination Therapeutics.Biology (Basel). 2020 Jul 23;9(8):187. doi: 10.3390/biology9080187. Biology (Basel). 2020. PMID: 32718025 Free PMC article. Review.
-
A Systematic Review of Apoptosis in Correlation With Cancer: Should Apoptosis Be the Ultimate Target for Cancer Treatment?Cureus. 2022 Aug 28;14(8):e28496. doi: 10.7759/cureus.28496. eCollection 2022 Aug. Cureus. 2022. PMID: 36185861 Free PMC article. Review.
-
CLCA2 as a p53-inducible senescence mediator.Neoplasia. 2012 Feb;14(2):141-9. doi: 10.1593/neo.111700. Neoplasia. 2012. PMID: 22431922 Free PMC article.
-
G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv.EMBO J. 2005 Sep 7;24(17):3093-103. doi: 10.1038/sj.emboj.7600769. Epub 2005 Aug 18. EMBO J. 2005. PMID: 16107883 Free PMC article.
-
Epimorphic regeneration in mice is p53-independent.Cell Cycle. 2010 Sep 15;9(18):3667-73. doi: 10.4161/cc.9.18.13119. Epub 2010 Sep 21. Cell Cycle. 2010. PMID: 20855943 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous